CHJWM
PFE icon

Carlton Hofferkamp & Jenks Wealth Management’s Pfizer PFE Stock Holding History

Carlton Hofferkamp & Jenks Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$347K Sell
13,974
-247
-2% -$6.46K 0.11% 109
2026
Q1 		$381K Sell
14,221
-943
-6% -$25.1K 0.13% 99
2025
Q4 		$378K Sell
15,164
-4,468
-23% -$113K 0.13% 102
2025
Q3 		$486K Sell
19,632
-3,538
-15% -$87.3K 0.16% 94
2025
Q2 		$552K Sell
23,170
-9,056
-28% -$211K 0.2% 87
2025
Q1 		$710K Sell
32,226
-1,199
-4% -$31.4K 0.29% 74
2024
Q4 		$884K Sell
33,425
-10,169
-23% -$276K 0.33% 68
2024
Q3 		$1.21M Sell
43,594
-3,094
-7% -$90.3K 0.46% 48
2024
Q2 		$1.47M Sell
46,688
-561
-1% -$15.4K 0.57% 44
2024
Q1 		$1.19M Sell
47,249
-3,596
-7% -$99.8K 0.5% 45
2023
Q4 		$1.44M Sell
50,845
-3,035
-6% -$91.7K 0.6% 43
2023
Q3 		$1.66M Sell
53,880
-4,824
-8% -$171K 0.77% 32
2023
Q2 		$2.06M Sell
58,704
-1,045
-2% -$40.7K 0.9% 27
2023
Q1 		$2.29M Sell
59,749
-3,602
-6% -$156K 1.04% 22
2022
Q4 		$2.77M Sell
63,351
-2,373
-4% -$114K 1.22% 20
2022
Q3 		$2.95M Sell
65,724
-1,381
-2% -$67.1K 1.39% 15
2022
Q2 		$3.57M Sell
67,105
-1,048
-2% -$53.4K 1.64% 13
2022
Q1 		$3.76M Sell
68,153
-1,099
-2% -$57K 1.54% 13
2021
Q4 		$3.64M Sell
69,252
-1,908
-3% -$94.5K 1.53% 13
2021
Q3 		$3.44M Sell
71,160
-360
-0.5% -$15.9K 1.38% 15
2021
Q2 		$2.89M Sell
71,520
-208
-0.3% -$8.09K 1.24% 20
2021
Q1 		$2.76M Buy
71,728
+2,182
+3% +$77.5K 1.23% 21
2020
Q4 		$2.55M Sell
69,546
-3,597
-5% -$132K 1.26% 21
2020
Q3 		$2.67M Buy
73,143
+2,256
+3% +$79.1K 1.4% 17
2020
Q2 		$2.64M Buy
70,887
+2,685
+4% +$91.2K 1.51% 16
2020
Q1 		$2.47M Buy
68,202
+2,953
+5% +$101K 1.52% 17
2019
Q4 		$2.49M Buy
65,249
+507
+0.8% +$18.1K 1.4% 20
2019
Q3 		$2.2M Buy
64,742
+902
+1% +$32.8K 1.35% 18
2019
Q2 		$2.59M Buy
63,840
+740
+1% +$29.4K 1.56% 16
2019
Q1 		$2.54M Sell
63,100
-408
-0.6% -$16.3K 1.59% 15
2018
Q4 		$2.63M Sell
63,508
-2,423
-4% -$101K 1.88% 11
2018
Q3 		$2.76M Sell
65,931
-178
-0.3% -$6.85K 1.69% 12
2018
Q2 		$2.28M Sell
66,109
-844
-1% -$28.8K 1.47% 15
2018
Q1 		$2.24M Sell
66,953
-1,290
-2% -$44.3K 1.51% 16
2017
Q4 		$2.35M Buy
68,243
+219
+0.3% +$7.47K 1.47% 13
2017
Q3 		$2.3M Sell
68,024
-2,238
-3% -$71.9K 1.47% 14
2017
Q2 		$2.24M Sell
70,262
-25
-0% -$788 1.52% 13
2017
Q1 		$2.28M Buy
70,287
+2,779
+4% +$87.6K 1.59% 12
2016
Q4 		$2.08M Buy
67,508
+771
+1% +$23.5K 1.51% 17
2016
Q3 		$2.14M Buy
66,737
+2,918
+5% +$97.6K 1.68% 16
2016
Q2 		$2.13M Sell
63,819
-604
-0.9% -$19.3K 1.68% 16
2016
Q1 		$1.81M Buy
64,423
+2,000
+3% +$57.1K 1.48% 17
2015
Q4 		$1.89M Buy
62,423
+1,055
+2% +$33.2K 1.62% 15
2015
Q3 		$1.83M Buy
61,368
+126
+0.2% +$4.04K 1.78% 14
2015
Q2 		$1.96M Buy
61,242
+235
+0.4% +$7.66K 1.83% 15
2015
Q1 		$2.01M Sell
61,007
-29
-0% -$922 2.01% 10
2014
Q4 		$1.8M Buy
61,036
+2,478
+4% +$71.1K 1.59% 13
2014
Q3 		$1.62M Buy
58,558
+25,007
+75% +$702K 1.86% 18
2014
Q2 		$944K Buy
33,551
+50
+0.1% +$1.43K 1.22% 28
2014
Q1 		$1.02M Sell
33,501
-210
-0.6% -$6.26K 1.33% 26
2013
Q4 		$979K Sell
33,711
-177
-0.5% -$5.15K 1.38% 25
2013
Q3 		$923K Buy
33,888
+10,990
+48% +$299K 1.48% 22
2013
Q2 		$608K Buy
+22,898
New +$633K 0.97% 31

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Carlton Hofferkamp & Jenks Wealth Management's PFE Position: Q2 2026 in Review

Carlton Hofferkamp & Jenks Wealth Management reduced its Pfizer (PFE) stake by 1.7% in Q2 2026, selling an estimated $6.46K and leaving 13,974 shares worth $347K. The position accounts for 0.11% of the portfolio, ranked #109.

Carlton Hofferkamp & Jenks Wealth Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.76M in Q1 2022. 1,031 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Carlton Hofferkamp & Jenks Wealth Management held 13,974 shares of Pfizer worth $347K as of Q2 2026.
  • Carlton Hofferkamp & Jenks Wealth Management sold 247 Pfizer shares in Q2 2026, an estimated $6.46K.
  • Pfizer made up 0.11% of Carlton Hofferkamp & Jenks Wealth Management's portfolio in Q2 2026, its #109 holding.
  • Carlton Hofferkamp & Jenks Wealth Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Carlton Hofferkamp & Jenks Wealth Management's Pfizer position peaked at $3.76M in Q1 2022.
  • 1,031 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Carlton Hofferkamp & Jenks Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.